(Press-News.org) The combined loss of two tumor suppressor genes, retinoblastoma (RB) and phosphatase and tensin homolog (PTEN) was shown to be strongly associated with progression of DCIS to invasive breast cancer, according to a study published November 28 in the Journal of the National Cancer Institute.
Ductal carcinoma in situ (DCIS) is a breast cancer precursor lesion for which there are no established markers defining risk of progression to invasive breast cancer. As a result, the majority of women are treated uniformly with surgery and radiation therapy potentially with additional hormonal therapy. However, only a subset of DCIS patients are at risk for developing potentially life-threatening invasive breast cancer requiring such treatment. Thus, defining these patients is a high priority for improving patient care by more effectively directing treatment of DCIS.
Dr. Agnieszka Witkiewicz, Department of Pathology at the University of Texas, Southwestern, and colleagues, assessed RB and PTEN expression in the tissue from over 200 DCIS patients who were treated by surgical resection. They analyzed the association of the loss of each tumor suppressor with DCIS recurrence and progression to invasive breast cancer and conducted functional studies of the two tumor suppressors in cell line models.
About one-third of the women in the study had either recurrence of DCIS or progression to invasive disease and RB loss was statistically significantly associated with recurrent DCIS. Although PTEN loss was not independently associated with clinical outcome, in combination with RB loss, PTEN deficiency defined DCIS cases that were at substantially increased risk for recurrence and progression. Women with DCIS lacking both RB and PTEN were over 5 times as likely to develop invasive breast cancer. Cellular studies demonstrated that each gene plays a distinct role in facilitating aberrant proliferation and invasive properties that contribute to disease progression.
Dr. Erik Knudsen, an author on the study, concluded that "RB and PTEN together have prognostic utility that could be used to define those DCIS cases that need to be treated aggressively." The authors note, however, that these findings are from only one cohort treated solely by surgery and therefore must be replicated in other cohorts and with additional therapeutic interventions such as radiation. Dr. Witkiewicz believes that, "Such planned studies will be particularly informative for providing a means to spare women from unnecessary radiation exposure and improve the care of women with DCIS." Dr. Knudsen also says, "Interventions exploiting tumor suppressor loss could be utilized to more effectively treat high-risk DCIS". The authors believe that such work will lead to a personalized/rational approach to the treatment of DCIS replacing the current "one size fits all" treatment.
###
Contact Info:
Article: Agnieszka K. Witkiewicz, M.D., nieszka@mac.com,
Erik S. Knudsen, Ph.D., knudsen.esk@gmail.com END
Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer
2012-11-29
ELSE PRESS RELEASES FROM THIS DATE:
COUP-TFII sparks prostate cancer progression
2012-11-29
HOUSTON – (Nov. 29, 2012) – Prostate cancer presents a dilemma for patients and the physicians who treat them. Which cancers are essentially indolent and present no risk and which are life threatening? Which can be watched and which need aggressive treatment?
Drs. Ming-Jer and Sophia Tsai, both professors in the department of molecular and cellular biology at Baylor College of Medicine, think a receptor called COUP-TFII that they have long studied may point the way to an answer. In a study that appears online in the journal Nature, they show that high levels (overexpression) ...
Genetic variation recent, varies among populations
2012-11-29
HOUSTON -- (Nov. 29, 2012) – Nearly three-quarters of mutations in genes that code for proteins – the workhorses of the cell – occurred within the past 5,000 to 10,000 years, fairly recently in evolutionary terms, said a national consortium of genomic and genetic experts, including those at Baylor College of Medicine.
"One of the most interesting points is that Europeans have more new deleterious (potentially disease-causing) mutations than Africans," said Dr. Suzanne Leal, professor of molecular and human genetics at BCM and an author of the report. She is also director ...
UC Davis researchers aid effort to sequence the complex wheat genome
2012-11-29
Intent on developing wheat varieties with higher yields and enhanced nutritional content, researchers at the University of California, Davis, have teamed up with scientists at nine other institutions in an attempt to sequence the wheat genome.
Results from that endeavor, led by researchers at the U.K.-based Biotechnology and Biological Sciences Research Council, will be reported Nov. 29 in the journal Nature.
"This work moves us one step closer to a comprehensive and highly detailed genome sequence for bread wheat, which along with rice and maize is one of the three ...
HIV treatment reduces risk of malaria recurrence in children, NIH funded study shows
2012-11-29
A combination of anti-HIV drugs has been found to also reduce the risk of recurrent malaria by nearly half among HIV-positive children, according to researchers supported by the National Institutes of Health.
The combination of protease inhibitors lopinavir and ritonavir contributed to an overall reduction of 40 percent in the rate of malaria among a group of HIV-positive infants and children up to 6 years old in Uganda who were also being treated with anti-malarial drugs. This reduction was in comparison to malaria incidence among children receiving a drug treatment ...
Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
2012-11-29
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
"This approach uses the power of genome sequencing to detect circulating tumor DNA in the blood, providing a sensitive method that can be used to detect and monitor cancers," says Victor Velculescu, M.D., Ph.D., professor of oncology and co-director of the Cancer Biology Program at Johns Hopkins.
A ...
Risk of childhood obesity can be predicted at birth
2012-11-29
A simple formula can predict at birth a baby's likelihood of becoming obese in childhood, according to a study published today in the open access journal PLOS ONE.
The formula, which is available as an online calculator, estimates the child's obesity risk based on its birth weight, the body mass index of the parents, the number of people in the household, the mother's professional status and whether she smoked during pregnancy.
The researchers behind the study hope their prediction method will be used to identify infants at high risk and help families take steps to ...
Liverpool scientists decipher genetic code of wheat
2012-11-29
Scientists at the University of Liverpool have deciphered the genetic code of wheat to help crop breeders increase yield and produce varieties that are better suited to a changing environment.
Wheat is one of the world's most important food crops, accounting for 20% of the world's calorific intake. Global wheat production, however, is under threat from climate change and an increase in demand from a growing human population.
The Liverpool team, at the University's Centre for Genomic Research, used new methods of sequencing DNA to decode the large wheat genome, ...
Testicular cancer risk tripled in boys whose testes fail to descend
2012-11-29
Boys whose testes have not descended at birth—a condition known as cryptorchidism—are almost three times as likely to develop testicular cancer in later life, finds an analysis of the available evidence published online in Archives of Disease in Childhood.
The findings prompt the authors to ask whether boys with the condition should be regularly monitored to lessen the potential risk
Cryptorchidsim, where testes fail to descend into the scrotum and are retained within the abdomen, is the most common birth defect in boys, affecting around 6% of newborns.
The authors ...
Texas astronomers measure most massive, most unusual black hole using Hobby-Eberly Telescope
2012-11-29
Fort Davis, Texas — Astronomers have used the Hobby-Eberly Telescope at The University of Texas at Austin's McDonald Observatory to measure the mass of what may be the most massive black hole yet — 17 billion Suns — in galaxy NGC 1277. The unusual black hole makes up 14 percent of its galaxy's mass, rather than the usual 0.1 percent. This galaxy and several more in the same study could change theories of how black holes and galaxies form and evolve. The work will appear in the journal Nature on Nov. 29.
NGC 1277 lies 220 million light-years away in the constellation Perseus. ...
Ponatinib acts against the most resistant types of chronic myeloid leukemia
2012-11-29
HOUSTON – A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of The New England Journal of Medicine.
All 12 patients in the trial with chronic phase CML and the T315I mutation had a complete hematologic response (absence of CML cells in the blood) after treatment with ponatinib. Eleven had a major reduction in CML cells in the bone marrow and nine achieved a complete cytogenetic response – no cells in the marrow.
T315I is present in up to 20 percent ...